RE: Great News to Come5 Feb 2021 09:33
Agree btb,
You would have thought one of the first questions Biden and his team would ask the FDA is - what do you have in the pipeline for approval, why is there a backlog, and what resources do you need to speed up the process for giving approvals to ramp up our capabilities here.
On the shares in issue front, I agree that it may just be an oversight. A change in % held through dilution should be RNS'd just like any buy/selll, unless they remain within the confines of a reportable threshold (i.e. it was at 3.8% but dilution took it to 3.2% so no threshold crossed).
My understanding anyway - other shares I hold have seen some TR1's produce produce an RNS for some holders, but not others.
It should be remembered that for TR1's it is the holder who has the responsibility to inform the issuer, and the issuer will only RNS if they get notification from a holder. It is not the responsibility of GDR to chase up any holders in this regard, but they are obliged to RNS every notification they receive, as I believe that the holder also notifies the FCA of their position too.
Also, it will most likely be the holders' custodian who makes the notification to the issuer, not the company, so nothing should be missed, although it is not as robust a system as it can be.
I believe it is confusion/unfamiliarity of the rules, rather than any deliberate act if notifications are not made